Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiujiao Wang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|September 29, 2023
ARIAS: An AR-based interactive advertising systemQiujiao Wang, Zhijie Xie
Frontiers in Oncology|March 15, 2021
Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating CancerBo Lin, Qiujiao Wang, Kun Liu, et al.
Journal of Tissue Engineering and Regenerative Medicine|March 23, 2022
Amniotic membrane mesenchymal stem cells-based therapy improves Bmi-1-deficient mandible osteoporosis through stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorptionYing Yin, Qiujiao Wang, Chunfeng Xie, et al.
Frontiers in Cell and Developmental Biology|April 26, 2021
AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to CancersBo Lin, Xu Dong, Qiujiao Wang, et al.
Journal of Cellular and Molecular Medicine|October 1, 2022
α-Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosisQiujiao Wang, Wei Li, Minni Zhang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|September 29, 2023
ARIAS: An AR-based interactive advertising systemQiujiao Wang, Zhijie Xie
Frontiers in Oncology|March 15, 2021
Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating CancerBo Lin, Qiujiao Wang, Kun Liu, et al.
Journal of Tissue Engineering and Regenerative Medicine|March 23, 2022
Amniotic membrane mesenchymal stem cells-based therapy improves Bmi-1-deficient mandible osteoporosis through stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorptionYing Yin, Qiujiao Wang, Chunfeng Xie, et al.
Frontiers in Cell and Developmental Biology|April 26, 2021
AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to CancersBo Lin, Xu Dong, Qiujiao Wang, et al.
Journal of Cellular and Molecular Medicine|October 1, 2022
α-Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosisQiujiao Wang, Wei Li, Minni Zhang, et al.
Pageof 1